Product image of Letter (Levothyroxine Sodium) supplied by GNH India

Letter

Active Ingredient:
Levothyroxine Sodium
Origin:
EU

Letter (Levothyroxine Sodium)

Levothyroxine sodium, the active ingredient in Letter, is a thyroid hormone presented as a tablet for oral use. It treats hypothyroidism by replacing deficient thyroid hormone in patients with an underactive thyroid.

GNH India supplies Letter as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sanofi - Produtos Farmaceuticos Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levothyroxine sodium is used in thyroid hormone replacement therapy to manage conditions caused by insufficient endogenous hormone.

  • Hypothyroidism: restores normal metabolic activity by providing exogenous thyroxine (T4).
  • Post‑thyroidectomy hormone replacement: maintains euthyroid status after surgical removal of the thyroid gland.
  • Congenital hypothyroidism: supplies necessary thyroid hormone to infants born with thyroid deficiency.

How It Works

  • Levothyroxine sodium is a synthetic form of the natural thyroid hormone thyroxine (T4). After oral absorption, it is converted to the active hormone triiodothyronine (T3) in peripheral tissues, binding to nuclear thyroid hormone receptors and regulating gene transcription that controls basal metabolic rate, protein synthesis, and growth.

Side Effects

Levothyroxine sodium may cause a range of adverse reactions, most of which are dose‑related.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Insomnia: difficulty falling or staying asleep.
  • Palpitations: sensation of rapid or irregular heartbeat.
  • Weight loss: unintended reduction in body weight.
  • Heat intolerance: increased sensitivity to warm environments.
  • Tremor: fine shaking of hands or limbs.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.
  • Angina pectoris: chest pain due to reduced coronary blood flow.
  • Myocardial infarction: heart attack in susceptible individuals.
  • Bone loss/osteoporosis: decreased bone mineral density with long‑term overtreatment.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Adrenal crisis: precipitated in patients with adrenal insufficiency.

Precautions & Warnings

Levothyroxine sodium requires careful monitoring to avoid over‑ or under‑replacement.

  • Dose titration: adjust based on thyroid function tests and clinical response.
  • Cardiovascular disease: use cautiously in patients with angina, arrhythmias, or recent myocardial infarction.
  • Pregnancy and lactation: consult a healthcare professional; dose may need adjustment.
  • Elderly patients: start with lower doses and monitor for cardiac effects.
  • Drug interactions: review concomitant medications that may affect absorption or metabolism.
  • Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Avoid Interactions

Levothyroxine sodium can have significant interactions that affect its absorption or hormonal activity.

Major Interactions (Avoid)

  • Calcium supplements: reduce levothyroxine absorption.
  • Iron salts: markedly decrease oral bioavailability.
  • Sucralfate: binds and impairs absorption.
  • Cholestyramine or other bile‑acid sequestrants: lower systemic exposure.
  • Antacids containing aluminum or magnesium: interfere with uptake.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
  • Diabetes medications: thyroid hormone changes can affect glucose control.
  • Antidepressants (SSRIs, tricyclics): may alter thyroid hormone levels.
  • Estrogen therapy: can increase levothyroxine requirement.
  • Statins: potential modest effect on thyroid hormone metabolism.

Frequently Asked Questions

Letter contains levothyroxine sodium, a synthetic thyroid hormone used to treat hypothyroidism and other conditions where the body lacks adequate thyroid hormone. It restores normal metabolic function by supplying the missing hormone.

Levothyroxine sodium is absorbed from the gastrointestinal tract and converted to the active hormone triiodothyronine (T3). It binds to nuclear thyroid receptors, influencing gene expression that regulates metabolism, growth, and development.

The appropriate dose of Letter is individualized and determined by the prescribing clinician based on the patient’s thyroid function tests, age, weight, and clinical response. Dosage adjustments are made during follow‑up.

Levothyroxine is generally considered safe in pregnancy and lactation when medically indicated, but dosing may need adjustment. Pregnant or nursing patients should discuss therapy with their healthcare provider to ensure optimal maternal and fetal outcomes.

To order Letter, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Letter provides levothyroxine sodium, the same active ingredient found in most thyroid hormone replacement products. Compared with combination T4/T3 preparations, levothyroxine alone offers a stable, predictable pharmacokinetic profile and is the standard of care for most hypothyroid patients.

Letter should be stored at ambient temperature below 25 °C, kept in its original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources to maintain product stability.

Letter is taken orally, usually on an empty stomach 30‑60 minutes before breakfast with a full glass of water. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious risks include cardiac arrhythmias, angina, myocardial infarction, severe bone loss, and allergic reactions. Over‑replacement can lead to hyperthyroid symptoms, while under‑replacement may fail to correct hypothyroidism. Regular monitoring is essential.

Letter should be avoided in patients with known hypersensitivity to levothyroxine or any excipients, untreated adrenal insufficiency, or uncorrected thyrotoxicosis. Clinicians must assess each individual’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.